
GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Sanofi, Novo Nordisk A/S, AstraZeneca
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The GLP-1 receptor agonist market would be worth USD 28.19 billion in 2025 and grow at a compound annual growth rate (CAGR) of 12.3% to reach USD 63.54 billion by 2032. The …